Method of reducing or preventing bone marrow hypoplasia
US5430045A · kind A · utility
9Cited by
35References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 1993 |
| Grant date | Jul 4, 1995 |
| Priority date | — |
| Expiry date | May 28, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for reducing, or preventing, bone marrow hypoplasia in a patient at risk of, or having, same. To this end, when a glutathione intracellular stimulator is administered to such a patient, the risk of bone marrow hypoplasia is reduced or prevented. In an embodiment, the composition for stimulating the intracellular glutathione levels comprises L-2-oxothiazolidine-4-carboxylate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.